EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Residual left atrial v wave predicts clinical outcome of transcatheter edge-to-edge mitral valve repair

Michael Paulus iD, Jonas Rösch, Franziska Grewe, Moritz Haus, Valeska Bienert, Michael Wester iD, Christian Schach, Andreas Luchner, Christoph Birner, Bernhard Unsöld, Lars S Maier, Kurt Debl und 1 weitere

ESC Heart Failure · 03.03.2026 · 13 (2)

DOI: 10.1093/eschf/xvag086 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift ESC Heart Failure, online erschienen am 23.03.2026. Verfasst von Michael Paulus und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine II, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, Regensburg 93053, Germany. Hauptthemen laut MEDLINE: Atrial Function, Left, Atrial Pressure, Cardiac Catheterization, Heart Atria. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Intraprocedural assessment of residual mitral regurgitation (MR) is crucial for the success of transcatheter edge-to-edge mitral valve repair (M-TEER), yet challenging in the case of ambiguous echocardiographic findings. Monitoring left atrial (LA) pressure can complement the evaluation of residual MR after device placement. This study aimed to determine the prognostic impact of intraprocedural changes in LA pressure on the clinical outcome following M-TEER.

Methods

We enrolled 299 patients undergoing M-TEER for primary or secondary MR in a prospective observational study. During the procedure, LA mean (LAmP) and LA v wave pressure (LAvP) were recorded before and after device implantation. The primary endpoint was death or hospitalization for heart failure during a 2-year follow-up.

Results

Mean age of the study population was 76.6 ± 8.2 years. Secondary mitral regurgitation was identified in 62.9% of the patients. Reduction to MR grade I or II was achieved in 95.3% of cases. During M-TEER, LAvP decreased from 30.5 ± 15.0 to 23.2 ± 10.4 mmHg (P < .001) after device implantation, accompanied by a modest reduction of LAmP from 16.6 ± 6.3 to 15.3 ± 5.9 mmHg (P = .006). LAvP post M-TEER was a strong predictor of death or hospitalization for heart failure in both univariate and multivariate analysis, independent of echocardiographic MR severity (hazard ratio per 10 mmHg 1.37 [1.15–1.63], P < .001 and 1.29 [1.06–1.57], P = .012). Residual LAvP below 25 mmHg was strongly associated with a favourable outcome irrespective of residual echocardiographic MR grade, including patients with residual MR grade I and II.

Conclusion

High residual LAvP predicts death or hospitalization for heart failure after M-TEER. LAvP after device implantation provides incremental prognostic information beyond echocardiographic MR grading and may therefore assist intraprocedural decision-making during M-TEER.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial Function, LeftAtrial PressureCardiac CatheterizationHeart AtriaHeart Valve Prosthesis ImplantationMitral ValveMitral Valve InsufficiencyAgedFemaleHumansMaleEchocardiography, TransesophagealFollow-Up StudiesPrognosisProspective StudiesTreatment OutcomeAged, 80 and over

Stichwörter der Autor:innen

Edge-to-edge repairLeft atrial pressureMitral regurgitationV wave

Autor:innen und Institutionen

  • Department of Internal Medicine II, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, Regensburg 93053, Germany.
  • Department of Cardiology, Hospital Barmherzige Brüder Regensburg, Regensburg, Germany.
  • Department of Internal Medicine I, Klinikum St.Marien, Amberg, Germany.
  • Medical Clinic I, Cardiology and Angiology, Justus-Liebig-University Giessen, Giessen, Germany.

ORCID-Profile: Michael Paulus, Michael Wester

Zitieren

APA

Paulus, M., Rösch, J., Grewe, F., Haus, M., Bienert, V., Wester, M., Schach, C., Luchner, A., Birner, C., Unsöld, B., Maier, L. S., Debl, K., & Meindl, C. (2026). Residual left atrial v wave predicts clinical outcome of transcatheter edge-to-edge mitral valve repair. ESC Heart Failure, 13(2). https://doi.org/10.1093/eschf/xvag086

Vancouver

Paulus M, Rösch J, Grewe F, Haus M, Bienert V, Wester M, et al. Residual left atrial v wave predicts clinical outcome of transcatheter edge-to-edge mitral valve repair. ESC Heart Failure. 2026;13(2). doi:10.1093/eschf/xvag086

BibTeX
@article{Paulus2026,
  author = {Paulus, Michael and Rösch, Jonas and Grewe, Franziska and Haus, Moritz and Bienert, Valeska and Wester, Michael and Schach, Christian and Luchner, Andreas and Birner, Christoph and Unsöld, Bernhard and Maier, Lars S and Debl, Kurt and Meindl, Christine},
  title = {Residual left atrial v wave predicts clinical outcome of transcatheter edge-to-edge mitral valve repair},
  journal = {ESC Heart Failure},
  year = {2026},
  volume = {13},
  number = {2},
  doi = {10.1093/eschf/xvag086}
}
Kostenlos starten →